AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 29, 2026

Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
Sep. 29, 2026

Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting

Indeterminate GlobeNewswire
Lite Strategy Reports Fiscal Year 2026 Financial Results
Sep. 29, 2026

Lite Strategy Reports Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire
Celularity Announces Naveen Jain to Join Board of Directors
Sep. 29, 2026

Celularity Announces Naveen Jain to Join Board of Directors

Indeterminate GlobeNewswire
TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy
Sep. 29, 2026

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

Indeterminate GlobeNewswire
Host Digital Letter to Shareholders
Sep. 29, 2026

Host Digital Letter to Shareholders

Indeterminate GlobeNewswire
J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives
Sep. 29, 2026

J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives

Indeterminate GlobeNewswire
Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis
Sep. 29, 2026

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Exercise of Warrants
Sep. 29, 2026

Silexion Therapeutics Announces Exercise of Warrants

Indeterminate GlobeNewswire
SLEEPLESS at Motion Fitness Sets $200k Goal for Mobile Mammograms with 24 Hour Treadmill Challenege
Sep. 29, 2026

SLEEPLESS at Motion Fitness Sets $200k Goal for Mobile Mammograms with 24 Hour Treadmill Challenege

Indeterminate EIN Presswire
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
Sep. 29, 2026

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

Indeterminate GlobeNewswire
Brunswick Corporation Announces Senior Leadership Appointments
Sep. 29, 2026

Brunswick Corporation Announces Senior Leadership Appointments

Indeterminate GlobeNewswire
Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
Sep. 29, 2026

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

Indeterminate GlobeNewswire
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
Sep. 29, 2026

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Indeterminate GlobeNewswire
Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Sep. 29, 2026

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Indeterminate GlobeNewswire
DiFusion to Define Therapeutic Biomaterials Category at NASS 2026
Sep. 29, 2026

DiFusion to Define Therapeutic Biomaterials Category at NASS 2026

Indeterminate GlobeNewswire
Provident Bank Survey: 7 in 10 Americans Are Rethinking Higher Education, and Nearly 1 in 3 Are Eyeing the Alternatives
Sep. 29, 2026

Provident Bank Survey: 7 in 10 Americans Are Rethinking Higher Education, and Nearly 1 in 3 Are Eyeing the Alternatives

Indeterminate GlobeNewswire
Aptean Positioned as a Leader in IDC MarketScape: Worldwide AI-enabled Operational ERP 2026 Vendor Assessment
Sep. 29, 2026

Aptean Positioned as a Leader in IDC MarketScape: Worldwide AI-enabled Operational ERP 2026 Vendor Assessment

Indeterminate GlobeNewswire
Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference
Sep. 29, 2026

Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference

Indeterminate GlobeNewswire
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
Sep. 29, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire
Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study
Sep. 29, 2026

Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.